Gel

In January, Traumagel, a plant-based hemostatic gel that controls bleeding in seconds when applied to a wound at the point of care, saw its commercial release in the United States.

Using triple-combination clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1% gel over layered topicals improved application evenness, according to a study.

The FDA has granted 510(k) clearance to a plant-based, hemostatic gel to treat moderate to severe bleeding, according to the manufacturer.

Designed for over-the-counter use, the Bentrio nasal spray from Altamira Therapeutics was more effective in treating nasal symptoms in seasonal allergic rhinitis than saline solution, according to a press release from the company.

The FDA approved a generic version of estradiol gel to treat moderate to severe vasomotor symptoms.

The FDA has granted over-the-counter authorization to Futura Medical for its topically applied gel treatment for erectile dysfunction as a de novo medical device, the company announced in a press release.

Novan released its financial results for the first quarter of 2023, which included continued progress towards its prescription drug user fee act goal date for berdazimer gel 10.3%, according to a company press release.

A new gel for treating acne vulgaris is set to undergo FDA review with the agency’s acceptance of a new drug application for investigational IDP-126, according to a press release from Bausch Health.

An exeporfinium chloride nasal gel called XF-73 was safe for patients and effectively decreased the burden of nasal Staphylococcus aureus, which lessens the risk of surgical site infections, researchers found.

NEW ORLEANS — A greater proportion of patients with molluscum contagiosum experienced complete clearance rates with berdazimer gel 10.3% vs. vehicle, according to a study presented at the American Academy of Dermatology Annual Meeting.